Your browser doesn't support javascript.
loading
The real-world outcomes of multiple myeloma patients treated with daratumumab.
Szabo, Agoston Gyula; Klausen, Tobias Wirenfeldt; Levring, Mette Bøegh; Preiss, Birgitte; Helleberg, Carsten; Breinholt, Marie Fredslund; Hermansen, Emil; Gjerdrum, Lise Mette Rahbek; Bønløkke, Søren Thorgaard; Nielsen, Katrine; Kjeldsen, Eigil; Iversen, Katrine Fladeland; Teodorescu, Elena Manuela; Dokhi, Marveh; Kurt, Eva; Strandholdt, Casper; Andersen, Mette Klarskov; Vangsted, Annette Juul.
Afiliação
  • Szabo AG; Department of Hematology, Vejle Hospital, Vejle, Denmark.
  • Klausen TW; Department of Hematology, Herlev University Hospital, Herlev, Denmark.
  • Levring MB; Department of Hematology, Odense University Hospital, Odense, Denmark.
  • Preiss B; Department of Pathology, Odense University Hospital, Odense, Denmark.
  • Helleberg C; Department of Hematology, Herlev University Hospital, Herlev, Denmark.
  • Breinholt MF; Department of Pathology, Herlev University Hospital, Herlev, Denmark.
  • Hermansen E; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
  • Gjerdrum LMR; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Bønløkke ST; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Nielsen K; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Kjeldsen E; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Iversen KF; Department of Hematology, Vejle Hospital, Vejle, Denmark.
  • Teodorescu EM; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
  • Dokhi M; Department of Hematology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
  • Kurt E; Department of Hematology, Regionshospitalet Holstebro, Holstebro, Denmark.
  • Strandholdt C; Department of Hematology, Esbjerg Hospital, Esbjerg, Denmark.
  • Andersen MK; Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.
  • Vangsted AJ; Department of Hematology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
PLoS One ; 16(10): e0258487, 2021.
Article em En | MEDLINE | ID: mdl-34644367
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Anticorpos Monoclonais / Mieloma Múltiplo Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Anticorpos Monoclonais / Mieloma Múltiplo Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Estados Unidos